200 related articles for article (PubMed ID: 38561434)
21. Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK Biobank.
Choi J; Jia G; Wen W; Shu XO; Zheng W
Am J Clin Nutr; 2021 Apr; 113(4):810-820. PubMed ID: 33675346
[TBL] [Abstract][Full Text] [Related]
22. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
Gu Y; Han F; Xue M; Wang M; Huang Y
BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
[TBL] [Abstract][Full Text] [Related]
23. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
Morois S; Fournier A; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC
Eur J Epidemiol; 2012 Jun; 27(6):439-52. PubMed ID: 22644109
[TBL] [Abstract][Full Text] [Related]
24. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
[TBL] [Abstract][Full Text] [Related]
25. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
26. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
27. Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study.
Ran SY; Yu Q; Chen Y; Lin SQ
Climacteric; 2017 Aug; 20(4):391-396. PubMed ID: 28523945
[TBL] [Abstract][Full Text] [Related]
28. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper.
Genazzani AR; Divakar H; Khadilkar SS; Monteleone P; Evangelisti B; Galal AF; Priego PIR; Simoncini T; Giannini A; Goba G; Benedetto C
Int J Gynaecol Obstet; 2024 Feb; 164(2):516-530. PubMed ID: 38178609
[TBL] [Abstract][Full Text] [Related]
29. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
Anagnostis EA
J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
[TBL] [Abstract][Full Text] [Related]
30. What the Women's Health Initiative has taught us about menopausal hormone therapy.
Chester RC; Kling JM; Manson JE
Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
[TBL] [Abstract][Full Text] [Related]
31. Effects of Screenings in Reducing Colorectal Cancer Incidence and Mortality Differ by Polygenic Risk Scores.
Choi J; Jia G; Wen W; Long J; Shu XO; Zheng W
Clin Transl Gastroenterol; 2021 May; 12(5):e00344. PubMed ID: 33955373
[TBL] [Abstract][Full Text] [Related]
32. Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study.
Archambault AN; Jeon J; Lin Y; Thomas M; Harrison TA; Bishop DT; Brenner H; Casey G; Chan AT; Chang-Claude J; Figueiredo JC; Gallinger S; Gruber SB; Gunter MJ; Guo F; Hoffmeister M; Jenkins MA; Keku TO; Le Marchand L; Li L; Moreno V; Newcomb PA; Pai R; Parfrey PS; Rennert G; Sakoda LC; Lee JK; Slattery ML; Song M; Win AK; Woods MO; Murphy N; Campbell PT; Su YR; Lansdorp-Vogelaar I; Peterse EFP; Cao Y; Zeleniuch-Jacquotte A; Liang PS; Du M; Corley DA; Hsu L; Peters U; Hayes RB
J Natl Cancer Inst; 2022 Apr; 114(4):528-539. PubMed ID: 35026030
[TBL] [Abstract][Full Text] [Related]
33. Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy.
Rudolph A; Hein R; Hoffmeister M; Försti A; Hemminki K; Risch A; Brenner H; Chang-Claude J
Int J Cancer; 2012 Sep; 131(5):E841-8. PubMed ID: 22234881
[TBL] [Abstract][Full Text] [Related]
34. Menopausal hormone therapy and breast cancer risk.
Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
[TBL] [Abstract][Full Text] [Related]
35. Precision hormone therapy: identification of positive responders.
Kim YJ; Brinton RD
Climacteric; 2021 Aug; 24(4):350-358. PubMed ID: 33615942
[TBL] [Abstract][Full Text] [Related]
36. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
[TBL] [Abstract][Full Text] [Related]
37. Hormone therapy and Hypertension in Postmenopausal Women: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Ferreira-Campos L; Gabrielli L; Almeida MDCC; Aquino EML; Matos SMA; Griep RH; Aras R
Arq Bras Cardiol; 2022 May; 118(5):905-913. PubMed ID: 35613189
[TBL] [Abstract][Full Text] [Related]
38. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
[TBL] [Abstract][Full Text] [Related]
39. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
40. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
